Fundraising FoxIntuitive Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
VahatiCor is developing the A-FLUX Reducer System, an interventional device to treat coronary microvascular dysfunction, a condition affecting millions of patients—particularly women—who experience chest pain and cardiac symptoms despite normal standard angiography results.
HardwareHealthtechMedical DevicesSanta Clara, US
Marwan Berrada(Founder and Chairman)inHarry Rowland(CEO)inKevin Van Bladel(Chief Technology Officer)inMark Niggli(Chief Commercial Officer)inMarwan Berrada-Sounni(Executive Officer, Director)in
BoardBrian R. Smith(Director)in
Co-investorsS3 Ventures
Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function.
BiotechHealthtechMedical DevicesMenlo Park, US
Karun Durgam Naga(Executive Officer, Director)
BoardHanson S. Gifford III(Director)Zack Scott(Director)inMichael A. Carusi(Director)Drew Field(Director)inDennis McWilliams(Director)in
Co-investorsF-Prime CapitalLightstone VenturesNorwest Venture PartnersStar51 CapitalBain Capital Life Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.